Stocktoria
Intellia Therapeutics, Inc. NTLA
Intellia Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| ARK Investment Management LLC | 16,875,684 | $285.5M | 14.51% |
| BlackRock Finance, Inc. | 9,597,607 | $214.8M | 8.25% |
| D. E. Shaw & Co., Inc. | 6,443,323 | $109.0M | 5.54% |
| TWO SIGMA INVESTMENTS, LP | 5,235,348 | $88.6M | 4.5% |
| RENAISSANCE TECHNOLOGIES LLC | 1,400,004 | $23.7M | 1.2% |
| CITADEL ADVISORS LLC | 788,812 | $13.3M | 0.68% |
| Point72 Asset Management, L.P. | 542,163 | $9.2M | 0.47% |
| AQR CAPITAL MANAGEMENT LLC | 492,954 | $8.3M | 0.42% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.